文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CD8 T 细胞功能障碍的特征在肿瘤抗原接触后数小时内就建立起来,此时细胞尚未开始分裂。

Hallmarks of CD8 T cell dysfunction are established within hours of tumor antigen encounter before cell division.

机构信息

Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA.

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

出版信息

Nat Immunol. 2023 Sep;24(9):1527-1539. doi: 10.1038/s41590-023-01578-y. Epub 2023 Aug 3.


DOI:10.1038/s41590-023-01578-y
PMID:37537361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10878719/
Abstract

Tumor-specific CD8+ T cells (TST) in patients with cancer are dysfunctional and unable to halt cancer progression. TST dysfunction, also known as exhaustion, is thought to be driven by chronic T cell antigen receptor (TCR) stimulation over days to weeks. However, we know little about the interplay between CD8 T cell function, cell division and epigenetic remodeling within hours of activation. Here, we assessed early CD8 T cell differentiation, cell division, chromatin accessibility and transcription in tumor-bearing mice and acutely infected mice. Surprisingly, despite robust activation and proliferation, TST had near complete effector function impairment even before undergoing cell division and had acquired hallmark chromatin accessibility features previously associated with later dysfunction/exhaustion. Moreover, continued tumor/antigen exposure drove progressive epigenetic remodeling, 'imprinting' the dysfunctional state. Our study reveals the rapid divergence of T cell fate choice before cell division in the context of tumors versus infection.

摘要

癌症患者的肿瘤特异性 CD8+ T 细胞(TST)功能失调,无法阻止癌症的进展。TST 功能失调,也称为衰竭,被认为是由数天到数周的慢性 T 细胞抗原受体(TCR)刺激驱动的。然而,我们对激活后数小时内 CD8 T 细胞功能、细胞分裂和表观遗传重塑之间的相互作用知之甚少。在这里,我们评估了荷瘤小鼠和急性感染小鼠中早期 CD8 T 细胞的分化、细胞分裂、染色质可及性和转录。令人惊讶的是,尽管 TST 有强烈的激活和增殖,但在细胞分裂之前,它们的效应功能几乎完全受损,并且已经获得了先前与晚期功能障碍/衰竭相关的标志性染色质可及性特征。此外,持续的肿瘤/抗原暴露导致进行性的表观遗传重塑,“印记”了功能障碍状态。我们的研究揭示了在肿瘤与感染的情况下,细胞分裂前 T 细胞命运选择的快速分歧。

相似文献

[1]
Hallmarks of CD8 T cell dysfunction are established within hours of tumor antigen encounter before cell division.

Nat Immunol. 2023-9

[2]
Exhaustion-associated regulatory regions in CD8 tumor-infiltrating T cells.

Proc Natl Acad Sci U S A. 2017-3-10

[3]
TOX is a critical regulator of tumour-specific T cell differentiation.

Nature. 2019-6-17

[4]
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

Immunity. 2016-8-16

[5]
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.

J Exp Med. 2022-2-7

[6]
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.

J Immunother Cancer. 2019-11-5

[7]
CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.

J Exp Med. 2002-6-3

[8]
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy.

J Immunother Cancer. 2021-3

[9]
T cell receptor and IL-2 signaling strength control memory CD8 T cell functional fitness via chromatin remodeling.

Nat Commun. 2022-4-26

[10]
Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8 T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation.

Int J Mol Sci. 2022-11-16

引用本文的文献

[1]
The glucose sensor NSUN2-mC modification regulates tumor-immune glucose metabolism reprogramming to drive hepatocellular carcinoma evolution.

Int J Biol Sci. 2025-7-11

[2]
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?

Trends Immunol. 2025-7-23

[3]
Early methionine availability attenuates T cell exhaustion.

Nat Immunol. 2025-7-23

[4]
Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells.

Cancers (Basel). 2025-7-2

[5]
Distinct evolutionary patterns of tumour-immune escape and elimination determined by extracellular matrix architectures.

J R Soc Interface. 2025-7

[6]
Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable model of exhaustion.

Immunother Adv. 2025-6-11

[7]
Systemic metabolic changes in acute and chronic lymphocytic choriomeningitis virus infection.

Mol Metab. 2025-6-26

[8]
Multiplexed profiling of single-cell secretion on a hierarchical loading microwell chip.

Biosens Bioelectron. 2025-11-1

[9]
Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control.

J Exp Med. 2025-9-1

[10]
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire.

J Immunother Cancer. 2025-5-2

本文引用的文献

[1]
CTCF mediates CD8+ effector differentiation through dynamic redistribution and genomic reorganization.

J Exp Med. 2023-4-3

[2]
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence.

Cancer Cell. 2022-7-11

[3]
cBAF complex components and MYC cooperate early in CD8 T cell fate.

Nature. 2022-7

[4]
A genome-scale screen for synthetic drivers of T cell proliferation.

Nature. 2022-3

[5]
monaLisa: an R/Bioconductor package for identifying regulatory motifs.

Bioinformatics. 2022-4-28

[6]
Batf-mediated epigenetic control of effector CD8 T cell differentiation.

Sci Immunol. 2022-2-18

[7]
Epigenetic scars of CD8 T cell exhaustion persist after cure of chronic infection in humans.

Nat Immunol. 2021-8

[8]
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation.

Nat Immunol. 2021-8

[9]
CD8 T cell differentiation and dysfunction in cancer.

Nat Rev Immunol. 2022-4

[10]
Memory-like HCV-specific CD8 T cells retain a molecular scar after cure of chronic HCV infection.

Nat Immunol. 2021-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索